CONTACT US:
    (805) 483 1185

All fields are required.

Close Appointment form

    CONTACT US:
    (805) 483 1185

    Pfizer, Valneva to co-develop Lyme disease vaccine

    • Home
    • Pfizer, Valneva to co-develop Lyme disease vaccine
    Pfizer, Valneva to co-develop Lyme disease vaccine
    Pfizer, Valneva to co-develop Lyme disease vaccine

    No Comments

    Pfizer, Valneva to co-develop Lyme disease vaccine

    Pfizer and Valneva recently announced that they will collaborate on developing Valneva’s Lyme disease vaccine candidate VLA15, presently in Phase 2 clinical studies.

    Valneva is eligible to receive a total of $308 million, including $130 million upfront, according to an April 30 news release.

    vaccine

    Source:Β https://www.drugdiscoverytrends.com/pfizer-valneva-to-co-develop-lyme-disease-vaccine/

    • Share This

    Related Posts

    Submit a comment

    Your email address will not be published. Required fields are marked *

    Leave a Reply

    You may use these HTML tags and attributes:

    <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>